E-DRUG: Paediatric ACTs for the treatment of uncomplicated malaria
-----------------------------------------------------------------------
Dear colleagues:
MMV is pleased to announce the release of a new independent study by consultant Dr. Florence Camus-Bablon, focused on assessing critical barriers to the acceptance and uptake of quality antimalarial medicines for children. The study examines six francophone countries in Central and West Africa, and draws on a WHO-endorsed framework for evaluating barriers to access to essential medicines. It suggests interventions that could enhance acceptance and uptake of WHO-recommended medicines for children. The findings and recommendations expressed in this study are those of the author, and do not necessarily reflect the views of MMV. The study can be accessed at:
http://www.mmv.org/newsroom/publications/identifying-and-moving-levers-acceptance-and-uptake-recommended-quality-assure
[please fix URL in browser if broken - moderator]
Thanks for your interest and feel free to send suggestions or comments to me (jagoeg@mmv.org) or Dr. Florence Camus-Bablon (fcb0305@hotmail.com).
--
George Jagoe
Medicines for Malaria Venture
jagoeg@mmv.org<mailto:jagoeg@mmv.org>
www.mmv.org<http://www.mmv.org>